Lee A Y, Akers K T, Collier M, Li L, Eisen A Z, Seltzer J L
Division of Dermatology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4424-9. doi: 10.1073/pnas.94.9.4424.
Normal fibroblasts cultured as monolayers secrete matrix metalloproteinases (MMP), including gelatinase A (72-kDa type IV collagenase) as inactive zymogens. Previously we found that normal fibroblasts cultured in a type I collagen lattice (dermal equivalent) secrete active gelatinase A. Here we show that the activation of progelatinase A occurs within the cell and that the activator copurifies with Golgi membranes. Cell extracts of fibroblasts cultured in collagen lattices contain active 62-kDa gelatinase A at least 4-6 h before active enzyme is detected in the culture medium. Pulse-chase experiments confirm these results. The activator is membrane-bound and localizes to the Golgi-enriched fraction. Highly purified plasma membranes from lattice cultures are unable to convert gelatinase A from the zymogen to its active form. The activator may be a metalloproteinase because EDTA prevents activation of exogenous proenzyme by membrane fractions. Membrane-type MMP1, the enzyme thought to be responsible for activation of gelatinase A on the plasma membrane of tumor cells, shows no significant change in either mRNA or protein levels during lattice culture. Intracellular levels of gelatinase A mRNA and protein increase during the culture period, and tissue inhibitor of metalloproteinases concentration does not change. Because of the greater availability of tissue inhibitor of metalloproteinases-free proenzyme as a substrate for the activator, it is possible that membrane-type MMP1 is the activating enzyme. In that case, malignant transformation may involve a change in the localization of the activator to the plasma membrane.
作为单层培养的正常成纤维细胞分泌基质金属蛋白酶(MMP),包括作为无活性酶原的明胶酶A(72 kDa IV型胶原酶)。此前我们发现,在I型胶原晶格(真皮替代物)中培养的正常成纤维细胞分泌活性明胶酶A。在此我们表明,前明胶酶A的激活发生在细胞内,且激活剂与高尔基体膜共纯化。在培养基中检测到活性酶之前至少4 - 6小时,胶原晶格中培养的成纤维细胞的细胞提取物中就含有活性62 kDa明胶酶A。脉冲追踪实验证实了这些结果。激活剂是膜结合的,定位于富含高尔基体的部分。来自晶格培养物的高度纯化的质膜无法将明胶酶A从酶原转化为其活性形式。激活剂可能是一种金属蛋白酶,因为EDTA可阻止膜组分对外源酶原的激活。膜型MMP1被认为是负责在肿瘤细胞质膜上激活明胶酶A的酶,在晶格培养过程中其mRNA和蛋白质水平均无显著变化。在培养期间,明胶酶A的mRNA和蛋白质的细胞内水平增加,而金属蛋白酶组织抑制剂的浓度没有变化。由于作为激活剂底物的无金属蛋白酶组织抑制剂的酶原可用性更高,膜型MMP1有可能是激活酶。在这种情况下,恶性转化可能涉及激活剂定位到质膜的变化。